Literature DB >> 10188877

Fibroblast radiosensitivity measured using the comet DNA-damage assay correlates with clonogenic survival parameters.

A M Eastham1, B Marples, A E Kiltie, C J Orton, C M West.   

Abstract

A study was made of the neutral comet assay as a potential method for measuring normal cell radiosensitivity. Eleven fibroblast strains were studied comprising nine derived from vaginal biopsies from pretreatment cervical cancer patients and two strains from radiosensitive individuals. DNA double strand break (dsbs) dose-response curves for both initial and residual (20-h repair time) damage were obtained over the dose range 0-240 Gy, with slopes varying 3.2 and 8-fold respectively. Clonogenic cell survival parameters were available for all the cell strains following both high- and low-dose rate irradiation. There were no correlations between the dose-response slope of the initial level of DNA dsbs and parameters that mainly describe the initial portion of clonogenic radiation survival curves (SF2, alpha, D). A significant correlation (r = -0.63, P = 0.04) was found between the extent of residual DNA dsbs and clonogenicity for all 11 fibroblast strains. The parameter showing the highest correlation with fibroblast cell killing (D) for the nine normal fibroblasts alone was the ratio of initial/residual DNA dsb dose-response slope (r = 0.80, P = < 0.01). A significant correlation (r = -0.67, P = 0.03) with clonogenic radiosensitivity was also found for all 11 cell strains when using the ratio of initial/residual DNA dsb damage at a single dose of 180 Gy. This study shows that fibroblast radiosensitivity measured using the neutral comet assay correlates with clonogenic radiation survival parameters, and therefore may have potential value in predictive testing of normal tissue radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188877      PMCID: PMC2374263          DOI: 10.1038/sj.bjc.6690219

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis.

Authors:  D Blöcher; D Sigut; M A Hannan
Journal:  Int J Radiat Biol       Date:  1991-11       Impact factor: 2.694

2.  Induction and rejoining of radiation-induced DNA single-strand breaks: "tail moment" as a function of position in the cell cycle.

Authors:  P L Olive; J P Banáth
Journal:  Mutat Res       Date:  1993-10       Impact factor: 2.433

3.  The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules.

Authors:  N G Burnet; J Nyman; I Turesson; R Wurm; J R Yarnold; J H Peacock
Journal:  Radiother Oncol       Date:  1994-12       Impact factor: 6.280

4.  Cellular radiosensitivity and DNA damage in primary human fibroblasts.

Authors:  R Wurm; N G Burnet; N Duggal; J R Yarnold; J H Peacock
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-10-15       Impact factor: 7.038

Review 5.  The comet assay: a comprehensive review.

Authors:  D W Fairbairn; P L Olive; K L O'Neill
Journal:  Mutat Res       Date:  1995-02       Impact factor: 2.433

6.  Lack of a correlation between radiosensitivity and DNA double-strand break induction or rejoining in six human tumor cell lines.

Authors:  P L Olive; J P Banáth; H S MacPhail
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

Review 7.  The complexity of DNA damage: relevance to biological consequences.

Authors:  J F Ward
Journal:  Int J Radiat Biol       Date:  1994-11       Impact factor: 2.694

8.  DNA double strand breaks in fibroblast cell lines, from non-Hodgkin's lymphoma patients, showing increased sensitivity to chronic gamma irradiation.

Authors:  M A Hannan; D Blöcher; D Sigut; M Waghray
Journal:  Cancer Lett       Date:  1991-05-01       Impact factor: 8.679

9.  The radiosensitivity of human fibroblast cell lines correlates with residual levels of DNA double-strand breaks.

Authors:  P K Zhou; A R Sproston; B Marples; C M West; G P Margison; J H Hendry
Journal:  Radiother Oncol       Date:  1998-06       Impact factor: 6.280

10.  DNA double-strand breaks measured in individual cells subjected to gel electrophoresis.

Authors:  P L Olive; D Wlodek; J P Banáth
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

View more
  6 in total

1.  Comparison of clonogenic assay with premature chromosome condensation assay in prediction of human cell radiosensitivity.

Authors:  Zhuan-Zi Wang; Wen-Jian Li; Hong Zhang; Jian-She Yang; Rong Qiu; Xiao Wang
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

2.  Use of the comet-FISH assay to compare DNA damage and repair in p53 and hTERT genes following ionizing radiation.

Authors:  Declan J McKenna; Bernadette A Doherty; C Stephen Downes; Stephanie R McKeown; Valerie J McKelvey-Martin
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

3.  Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment.

Authors:  Desheng Weng; Monique C Cunin; Baizheng Song; Brendan D Price; Mark S Eller; Barbara A Gilchrest; Stuart K Calderwood; Jianlin Gong
Journal:  Breast Cancer Res       Date:  2010-09-16       Impact factor: 6.466

4.  XAV939-mediated ARTD activity inhibition in human MB cell lines.

Authors:  Cristiano Renna; Roberta Salaroli; Claudia Cocchi; Giovanna Cenacchi
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

5.  Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity.

Authors:  M A L Moneef; B T Sherwood; K J Bowman; R C Kockelbergh; R P Symonds; W P Steward; J K Mellon; G D D Jones
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

Review 6.  Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.

Authors:  Mohammad Habash; Luis C Bohorquez; Elizabeth Kyriakou; Tomas Kron; Olga A Martin; Benjamin J Blyth
Journal:  Cancers (Basel)       Date:  2017-10-27       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.